about
Understanding the Activity of Antibiotics in Cerebrospinal Fluid in vitroSafety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsCell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat dataIn vivo P-glycoprotein function before and after epilepsy surgery.Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid.Removal of fractured endodontic instruments using an Nd:YAG laser.Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers.Immunomodulatory effects of fosfomycin in experimental human endotoxemia.Clinical applications of levofloxacin for severe infections.Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitisRituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical responseRifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.A Prediction Method for P-glycoprotein-Mediated Drug-Drug Interactions at the Human Blood-Brain Barrier From Blood Concentration-Time Profiles, Validated With PET Data.Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PETEffect of cardiopulmonary bypass on regional antibiotic penetration into lung tissue.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain BarrierKetolides--the modern relatives of macrolides : the pharmacokinetic perspective.[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors.Intravenous Fluid Challenge Decreases Intracellular Volume: A Bioimpedance Spectroscopy-Based Crossover Study in Healthy Volunteers.Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.Cerebral and Peripheral Metabolism to Predict Successful Reperfusion After Cardiac Arrest in Rats: A Microdialysis Study.Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain.Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline FosamilAssessing pharmacokinetics of different doses of fosfomycin in laboratory rats enables adequate exposure for pharmacodynamic models.Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
P50
Q28066832-A04C1F3B-119C-4D73-BF16-F6F9A0DA38AFQ30210481-E7AC0D0B-606E-4392-B991-3C351F6906FCQ30224497-BB3D9E72-5439-46B6-BA5D-28C532BD816EQ30395944-59E36CC1-1E0A-4EFE-9237-48F7CFD2C547Q30414998-75B05C47-540B-4758-9686-5D851433731DQ33802909-5A862B24-0763-4158-B03E-2920DDDF392BQ33836578-ED57339B-F5EE-4928-B516-14268E88EC48Q34100185-9762FDAD-9D91-431F-80C5-3AF72F845186Q34303793-523D85F9-4910-4FA6-8C8F-77E9774DD09BQ34508161-3D4C12A3-A087-45F9-811F-AA50A91CAC54Q35171844-0A625DEA-9867-4AEB-9BA6-EEDB268EFAF7Q35666586-62188801-A4A5-4677-9C35-B9BF354E944CQ35759103-1160BEB4-251D-4E14-A64A-2A07050B8D44Q35866694-30326110-90C9-4E10-88D6-3C9F3907E5E8Q36086437-99E44EAD-5C7D-4028-B2F4-30FA987A1B12Q36216264-303703A5-DB73-4C74-B695-8DA601C74743Q36231937-C9078558-B9F5-437E-B3EC-EE5FE7DCE2DAQ36338999-C0314D81-CC20-423B-AE83-C0896F9D995EQ36947632-48FD72FC-06B8-4D6A-9A49-7FEE2EED626AQ36949068-9FEB7954-9306-41B7-82D5-A9C9518C3FAEQ36969900-A41A2942-ECD6-474B-A054-22E57796B2D4Q37149078-6ECFA58D-7C29-47F4-9467-3ADC92F368E4Q37164563-EDB7BB38-8927-4310-BCC6-8BB1FAC1336CQ37345756-F6C987DE-2494-4113-A692-C8CCB9FC9F90Q37568411-395D76DE-C823-4F96-8BCA-1F7449DFC016Q38200490-62EB29D3-FFD9-4BD0-8116-FF95289EFFDEQ38552109-7EE4C6FC-CD0C-4213-AB2A-FC51C93DB5A6Q38603063-B067A482-5C2F-4D4B-AD35-23B7C60B33ACQ38703436-EB32B5CA-369A-49E8-A6AB-54113378359FQ38841102-DED13A36-555E-496D-908D-4FC8B69F2FE6Q38868938-3BE9A28E-AD48-46D0-AA70-84AB42F9C30AQ38931380-6A1AD490-4294-4D20-B258-DE6470B3596FQ38941366-8088FCB9-01B5-4BA0-9113-694426DD306DQ39153521-A3ECB223-401A-48A9-841A-B38FA4A5C688Q39153527-EF0BD5D7-1F45-4880-ACD5-C9DE6C06F4AFQ39153535-56550208-A848-49B8-9630-F47C4DA56F6EQ39198275-694B2ED1-DAE9-4540-9CCE-C5C923E038AFQ39226965-0B6D719F-DDFD-47B8-8A4F-DA4BE06591FDQ39254911-82DF0F4F-5DE7-4851-882A-CB8417E4D01FQ39278957-FDDCA894-C5C8-4F2D-B004-41BA0DD53162
P50
description
researcher
@en
wetenschapper
@nl
name
Markus Alexander Zeitlinger
@en
Markus Alexander Zeitlinger
@nl
type
label
Markus Alexander Zeitlinger
@en
Markus Alexander Zeitlinger
@nl
prefLabel
Markus Alexander Zeitlinger
@en
Markus Alexander Zeitlinger
@nl
P106
P31
P496
0000-0002-1873-3953